These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 22289844)
1. Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. Wouthuyzen-Bakker M; Bijvelds MJ; de Jonge HR; De Lisle RC; Burgerhof JG; Verkade HJ Pediatr Res; 2012 Jan; 71(1):4-12. PubMed ID: 22289844 [TBL] [Abstract][Full Text] [Related]
2. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Bijvelds MJ; Bronsveld I; Havinga R; Sinaasappel M; de Jonge HR; Verkade HJ Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257 [TBL] [Abstract][Full Text] [Related]
3. Small intestinal glucose absorption in cystic fibrosis: a study in human and transgenic DeltaF508 cystic fibrosis mouse tissues. Hardcastle J; Harwood MD; Taylor CJ J Pharm Pharmacol; 2004 Mar; 56(3):329-38. PubMed ID: 15025858 [TBL] [Abstract][Full Text] [Related]
4. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. De Lisle RC; Roach EA; Norkina O J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):46-52. PubMed ID: 16385253 [TBL] [Abstract][Full Text] [Related]
5. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Norkina O; Burnett TG; De Lisle RC Infect Immun; 2004 Oct; 72(10):6040-9. PubMed ID: 15385508 [TBL] [Abstract][Full Text] [Related]
6. Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol. Bertolini A; Bloks VW; Wilmink M; Bos E; van de Peppel IP; Eilers R; Prins S; Thomas R; de Bruin A; Verkade H; Jonker JW J Cyst Fibros; 2024 May; 23(3):461-473. PubMed ID: 37775443 [TBL] [Abstract][Full Text] [Related]
7. Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse. De Lisle RC; Mueller R; Boyd M J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):371-9. PubMed ID: 21970994 [TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice. Bodewes FA; Wouthuyzen-Bakker M; Bijvelds MJ; Havinga R; de Jonge HR; Verkade HJ Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1035-42. PubMed ID: 22301109 [TBL] [Abstract][Full Text] [Related]
9. Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies. Debray D; Rainteau D; Barbu V; Rouahi M; El Mourabit H; Lerondel S; Rey C; Humbert L; Wendum D; Cottart CH; Dawson P; Chignard N; Housset C Gastroenterology; 2012 Jun; 142(7):1581-91.e6. PubMed ID: 22370478 [TBL] [Abstract][Full Text] [Related]
10. Altered intestinal bile salt biotransformation in a cystic fibrosis (Cftr-/-) mouse model with hepato-biliary pathology. Bodewes FA; van der Wulp MY; Beharry S; Doktorova M; Havinga R; Boverhof R; James Phillips M; Durie PR; Verkade HJ J Cyst Fibros; 2015 Jul; 14(4):440-6. PubMed ID: 25633479 [TBL] [Abstract][Full Text] [Related]
11. No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. Werner A; Bongers ME; Bijvelds MJ; de Jonge HR; Verkade HJ J Lipid Res; 2004 Dec; 45(12):2277-86. PubMed ID: 15466369 [TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome. Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416 [TBL] [Abstract][Full Text] [Related]